Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human ( DrugBank: - )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
96	クローン病	17
97	潰瘍性大腸炎	14

96. クローン病

臨床試験数 : 2,400 / 薬物数 : 1,391 - (DrugBank : 267) / 標的遺伝子数 : 170 - 標的パスウェイ数 : 215

diseases per page:

Showing 1 to 10 of 17 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2019-001866-14-IT (EUCTR)	21/12/2021	12/10/2021	Open-label Extension Study of Brazikumab in Crohn's Disease	An Open-label, Long-term Extension Study of Brazikumab in Participants With Moderately to Severely A ...	Moderately to Severely Active Crohn's Disease. MedDRA version: 20.0;Level: LLT;Classification code 1 ...	Product Name: Brazikumab Product Code: [MEDI2070] INN or Proposed INN: ( L ) ASCORBATO DI CALCIO Other ...	ASTRAZENECA AB	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	150	Phase 3	United States;Czechia;Taiwan;Slovakia;Spain;Ukraine;Austria;Israel;Russian Federation;United Kingdom ...
2	EUCTR2019-001866-14-HU (EUCTR)	09/11/2021	02/08/2021	Open-label Extension Study of Brazikumab in Crohn’s Disease	An Open-label, Long-term Extension Study of Brazikumab in Participants With Moderately to Severely A ...	Moderately to Severely Active Crohn’s Disease MedDRA version: 20.0;Level: LLT;Classification code 10 ...	Product Name: Brazikumab Product Code: MEDI2070 INN or Proposed INN: BRAZIKUMAB Other descriptive name: ...	AstraZeneca AB	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	150	Phase 3	United States;Czechia;Taiwan;Slovakia;Spain;Ukraine;Austria;Israel;Russian Federation;United Kingdom ...
3	EUCTR2019-001866-14-ES (EUCTR)	27/10/2021	30/09/2020	Open-label Extension Study of Brazikumab in Crohn’s Disease	An Open-label, Long-term Extension Study of Brazikumab in Participants with Moderately to Severely A ...	Moderately to Severely Active Crohn’s Disease MedDRA version: 20.0;Level: LLT;Classification code 10 ...	Product Name: Brazikumab Product Code: Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human INN or Propo ...	Allergan Limited	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	1000	Phase 3	China;Korea, Republic of;United States;Taiwan;Spain;Ukraine;Austria;Russian Federation;Israel;United ...
4	EUCTR2018-004346-42-HU (EUCTR)	15/10/2021	31/01/2020	A Study of the Efficacy and Safety of Brazikumab in Participants with Moderately to Severely Active ...	A 52-Week, Multicenter, Randomized, Double-blind, Placebo and Active-Controlled, Operationally Seaml ...	Crohn's Disease MedDRA version: 20.0;Level: LLT;Classification code 10011402;Term: Crohn's disease ( ...	Product Name: Brazikumab Product Code: MEDI2070 INN or Proposed INN: BRAZIKUMAB Other descriptive name: ...	AstraZeneca AB	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	553	Phase 2;Phase 3	United States;Czechia;Taiwan;Slovakia;Spain;Ukraine;Austria;Israel;Russian Federation;United Kingdom ...
5	EUCTR2019-001866-14-PL (EUCTR)	27/09/2021	08/09/2021	Open-label Extension Study of Brazikumab in Crohn’s Disease	An Open-label, Long-term Extension Study of Brazikumab in Participants With Moderately to Severely A ...	Moderately to Severely Active Crohn’s Disease MedDRA version: 20.0;Level: LLT;Classification code 10 ...	Product Name: Brazikumab Product Code: MEDI2070 INN or Proposed INN: BRAZIKUMAB Other descriptive name: ...	AstraZeneca AB	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	150	Phase 3	United States;Czechia;Taiwan;Slovakia;Spain;Ukraine;Austria;Israel;Russian Federation;United Kingdom ...
6	EUCTR2019-001866-14-DE (EUCTR)	10/09/2021	11/06/2021	Open-label Extension Study of Brazikumab in Crohn’s Disease	An Open-label, Long-term Extension Study of Brazikumab in Participants With Moderately to Severely A ...	Moderately to Severely Active Crohn’s Disease MedDRA version: 20.0;Level: LLT;Classification code 10 ...	Product Name: Brazikumab Product Code: MEDI2070 INN or Proposed INN: BRAZIKUMAB Other descriptive name: ...	AstraZeneca AB	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	150	Phase 3	United States;Czechia;Taiwan;Slovakia;Spain;Ukraine;Austria;Israel;Russian Federation;United Kingdom ...
7	EUCTR2018-004346-42-IT (EUCTR)	03/09/2020	24/05/2021	An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Act ...	A 52-Week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo and Active-controlled, Opera ...	Crohn's Disease MedDRA version: 20.0;Level: LLT;Classification code 10011402;Term: Crohn's disease ( ...	Product Name: Brazikumab Product Code: [Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Huma INN or Propo ...	ALLERGAN LIMITED	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	2000	Phase 2;Phase 3	United States;Czechia;Spain;Ukraine;Austria;Israel;Russian Federation;United Kingdom;Italy;France;Cz ...
8	EUCTR2018-004346-42-AT (EUCTR)	18/06/2020	21/01/2020	A study of the Efficacy and Safety of Brazikumab in Participants with Moderately to Severly Active C ...	A 52-Week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo and Active-controlled, Opera ...	Crohn's Disease MedDRA version: 20.0;Level: LLT;Classification code 10011402;Term: Crohn's disease ( ...	Product Name: Brazikumab Product Code: MEDI2070 INN or Proposed INN: BRAZIKUMAB Other descriptive name: ...	Astrazeneca AB	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	600	Phase 2;Phase 3	United States;Czechia;Taiwan;Slovakia;Spain;Ukraine;Austria;Israel;Russian Federation;United Kingdom ...
9	EUCTR2018-004346-42-BG (EUCTR)	28/05/2020	08/01/2020	An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Act ...	A 52-Week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo and Active-controlled, Opera ...	Crohn's Disease MedDRA version: 20.0;Level: LLT;Classification code 10011402;Term: Crohn's disease ( ...	Product Name: Brazikumab Product Code: Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human INN or Propo ...	Allergan Ltd.	NULL	Not Recruiting	Female: yes Male: yes	2000	Phase 2;Phase 3	United States;Spain;Ukraine;Austria;Israel;Russian Federation;United Kingdom;Italy;France;Czech Repu ...
10	EUCTR2018-004346-42-RO (EUCTR)	19/05/2020	18/03/2022	An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Act ...	A 52-Week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo and Active-controlled, Opera ...	Crohn's Disease MedDRA version: 20.0;Level: LLT;Classification code 10011402;Term: Crohn's disease ( ...	Product Name: Brazikumab Product Code: Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human INN or Propo ...	Allergan Ltd.	NULL	Not Recruiting	Female: yes Male: yes	2000	Phase 2;Phase 3	United States;Czechia;Spain;Ukraine;Austria;Israel;Russian Federation;United Kingdom;Italy;France;Cz ...

First Previous1 2Next Last

先頭へ

97. 潰瘍性大腸炎

臨床試験数 : 2,527 / 薬物数 : 1,465 - (DrugBank : 259) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

diseases per page:

Showing 1 to 10 of 14 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2021-001644-10-HU (EUCTR)	04/02/2022	15/12/2021	Open-label Extension Study of Brazikumab in Ulcerative Colitis	A Phase 2 Open-label, Long-term Extension Safety Study of Brazikumab in Participants with Moderately ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Brazikumab Product Code: MEDI2070 INN or Proposed INN: BRAZIKUMAB Other descriptive name: ...	AstraZeneca AB	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	180	Phase 2	United States;Czechia;Taiwan;Spain;Ukraine;Austria;Israel;Russian Federation;United Kingdom;Italy;In ...
2	EUCTR2021-001644-10-IT (EUCTR)	21/12/2021	17/09/2021	Open-label Extension Study of Brazikumab in Ulcerative Colitis	A Phase 2 Open-label, Long-term Extension Safety Study of Brazikumab in Participants with Moderately ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Brazikumab Product Code: [MEDI2070] INN or Proposed INN: ( L ) ASCORBATO DI CALCIO Other ...	ASTRAZENECA AB	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	180	Phase 2	United States;Czechia;Taiwan;Spain;Ukraine;Austria;Israel;Russian Federation;United Kingdom;Italy;In ...
3	EUCTR2021-001644-10-ES (EUCTR)	30/11/2021	12/08/2021	Open-label Extension Study of Brazikumab in Ulcerative Colitis	A Phase 2 Open-label, Long-term Extension Safety Study of Brazikumab in Participants with Moderately ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Brazikumab Product Code: MEDI2070 INN or Proposed INN: BRAZIKUMAB Other descriptive name: ...	AstraZeneca AB	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	180	Phase 2	United States;Czechia;Taiwan;Spain;Ukraine;Austria;Israel;Russian Federation;United Kingdom;Italy;In ...
4	EUCTR2018-001605-93-HU (EUCTR)	22/11/2021	05/05/2020	Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative ...	A 54-Week, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 2 Study t ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Brazikumab Product Code: MEDI2070 INN or Proposed INN: BRAZIKUMAB Other descriptive name: ...	AstraZeneca AB	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	255	Phase 2	United States;Czechia;Taiwan;Spain;Ukraine;Austria;Israel;Russian Federation;United Kingdom;Italy;In ...
5	EUCTR2018-001605-93-DE (EUCTR)	20/05/2020	04/06/2019	Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative ...	A 54-Week, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 2 Study t ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Brazikumab Product Code: MEDI2070 INN or Proposed INN: BRAZIKUMAB Other descriptive name: ...	AstraZeneca AB	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	255	Phase 2	United States;Czechia;Taiwan;Spain;Ukraine;Austria;Israel;Russian Federation;United Kingdom;Italy;In ...
6	EUCTR2018-001605-93-AT (EUCTR)	09/03/2020	07/11/2019	Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative ...	A 54-Week, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 2 Study t ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Brazikumab Product Code: MEDI2070 INN or Proposed INN: BRAZIKUMAB Other descriptive name: ...	AstraZeneca AB	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	255	Phase 2	United States;Czechia;Taiwan;Spain;Ukraine;Austria;Israel;Russian Federation;United Kingdom;Italy;In ...
7	EUCTR2018-001605-93-CZ (EUCTR)	21/11/2019	05/08/2019	Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative ...	A 54-Week, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 2 Study t ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Brazikumab Product Code: MEDI2070 INN or Proposed INN: BRAZIKUMAB Other descriptive name: ...	AstraZeneca AB	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	255	Phase 2	United States;Czechia;Taiwan;Spain;Ukraine;Austria;Israel;Russian Federation;United Kingdom;Italy;In ...
8	EUCTR2018-001605-93-RO (EUCTR)	10/10/2019	15/03/2022	An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Act ...	A 54-Week Treatment, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo and Active-Control ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Brazikumab Product Code: Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human INN or Propo ...	Allergan Ltd.	NULL	Not Recruiting	Female: yes Male: yes	900	Phase 2	United States;Taiwan;Spain;Israel;Russian Federation;Colombia;Switzerland;Italy;India;France;Malaysi ...
9	EUCTR2018-001605-93-BG (EUCTR)	09/10/2019	20/09/2019	An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Act ...	A 54-Week Treatment, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo and Active-Control ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Brazikumab Product Code: Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human INN or Propo ...	Allergan Ltd.	NULL	Not Recruiting	Female: yes Male: yes	375	Phase 2	United States;Taiwan;Spain;Israel;Russian Federation;Colombia;Switzerland;Italy;India;France;Malaysi ...
10	EUCTR2018-001605-93-IT (EUCTR)	26/09/2019	29/01/2021	An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Act ...	A 54-Week Treatment, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo and Active-Control ...	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative col ...	Product Name: Brazikumab Product Code: [Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Huma INN or Propo ...	ALLERGAN LIMITED	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	375	Phase 2	United States;Taiwan;Spain;Israel;Russian Federation;Colombia;Switzerland;Italy;India;France;Malaysi ...

First Previous1 2Next Last

先頭へ